Consent and long-term neuroleptic treatment

N. R. Harris, K. Lovell, J. C. Day

    Research output: Contribution to journalArticlepeer-review


    The involvement of clients in the process of developing their care and treatment package is well established. If a genuine collaboration in treatment is achieved one of the fundamental bases of this process lies with 'informed consent'. Neuroleptic medication forms the basis of relapse prevention treatment for people suffering from schizophrenia with non-adherence to treatment seen as the largest cause of relapse. This paper reviews the complex and difficult issues in obtaining informed consent for this client group from within the context of the nurse's role and the problems that arise as a consequence of the blurring of professional boundaries. Throughout the paper reference is made to the expectations made by the UKCC, which provides clarification of nurses' practice in this area.
    Original languageEnglish
    Pages (from-to)475-482
    Number of pages7
    JournalJournal of Psychiatric and Mental Health Nursing
    Issue number4
    Publication statusPublished - 2002


    • Consent
    • Neuroleptic
    • Nursing practice
    • Relapse prevention
    • Schizophrenia
    • UKCC


    Dive into the research topics of 'Consent and long-term neuroleptic treatment'. Together they form a unique fingerprint.

    Cite this